The main characteristics of the ingredients of the Flu-M vaccine and an indicator of quality are their ability to develop an effective immune response against strains circulating in the world and of great epidemiological importance.
In the technological production process, optimal production conditions are adapted for:
- Maintaining stable antigen-protective properties necessary to ensure effective antigen-cell interaction, and maintaining the so-called "confirmatory protective epitope".
- Manufacturing of pharmaceutical products that meet all international requirements.
The protein hemagglutinin is a key protective antigen. Hemagglutinin is an integral membrane protein with a tendency to aggregation. Flu-M contains a stabilizer that prevents hemagglutinin aggregation and loss of its antigenic qualities.
Highly purified antigens of low reactogenicity are used to obtain FLU-M®.
The vaccine has a relatively low level of side effects, its characteristics of immunobiological activity comply with international requirements for influenza vaccines and guarantee immunity against influenza after its administration.